Intellectual Property
Minneapolis/St. Paul
Types of Intellectual Property Protection
Biologics vs Small Molecules
Hard Assets
Genericide
Tools for Auditing a Patent Portfolio
Outside of Law
Rewards of the Practice
Patents and Practicing an Invention
Patent Profile Analytics and Researchers
Confidential Information and Business Damage
When to Do a Freedom to Operate
What is a Trademark?
Importance of Getting a Patent
Freedom to Operate
What is a BioSimilar?
Establishing Confidentiality
What Should a Company Patent?
What is an Invention?
Intent of Patent Laws
Third Party Confidentiality
Joint Venture Ground Rules
Traditional Re-Examination
Technical Background
Value Management Lifecycle
Evaluation Agreement and Computer Codes
How Much Does it Cost to Get a Patent?
Refused Trademark Recourse
Attributes of a Good Patent
Risks of Not Patenting
Get Your Assignments Straight - Contribution of Owners
Forms of Confidential Information
Patent Strategy Considerations
Renewing a Trademark Registration
Qualifying for a Patent
PTAB Timing Trial Dynamics
Patents 101
Improperly Marked Product
Copyright
What Doesn't a Patent Provide?
What is a BioSimilar Product Under US Law?
Attorneys and Patent Profile Analytics
How to Navigate BioSimilar Challenges
Impact of US Hatch Waxman Act 1984
Independent Claim vs Dependent Claim
ITU
Effective Stay Strategy
Marking a Product
Trademark Filing Considerations
Post-Grant Options and Grounds of Challenge
Raising Good Prosecution Visibility
Who Determines Substitution Factors?
Ideal Patent Strategy
Consequences of Disclosing Confidential Information
The Case of the Joint Marketing Agreement Gone Bad
Implementing a Value-Driven Portfolio Process
Experience
How Does the Knowledge Gap Worsen Over Time?
Picking a Trademark
Background
How Should IP be Considered for Acquisition?
By the Numbers Overview
FDA Guidelines for Demonstrating Biosimilarity
Consequences of a Poorly Drafted Patent
Picking a Domain Name
Trademark
Low Risk Joint Ventures
What Engineers Can Learn from Patent Profile Analytics
Meet Mark Stignani
"Whens" - Audit Action Sheet
NDAs and Computer Codes
Post-Grant Options and Cost
Cost/Value Curve of a High Level Patent
How Does the Knowledge Gap Develop?
Wasting Money on Low-Value Patents
IP Registration Density
Patent Profile Analytics and Engineers
"Wheres" - Audit Action Sheet
Provisional Patent
Moderate Risk Joint Ventures
Equal Value Patents
Forward Citation Landscape
What Do I Give up in Getting My Patent?
What Does an Audit Action Sheet Look Like?
Specimen
Should IP be Part of Our Business Plan?
Different Parts of a Patent Document
Post-Grant Options
Litigation and BioSimilar Patenting
Infringing on Another Patent
How is the Entire Patent Considered Prior Art?
Interpretational Differences Between Prosecution and Litigation
Cost of Registering a Trademark
How do Patent Prosecution Services Vary in Value?
Patents and Other Forms of Intellectual Property Protection
How is Schwegman Lundberg & Woessner Different?
Intellectual Property Protection
Calculating New Investments
BioSimilar Patenting Litigation Involving Large Amounts of Money
Patent Profile Analytics and Managers
Why Should Claims Not Be Read on the Prior Art?
Patent Status Updates
Patent Analytics and Competition
What Should a Company Understand at the End of an IP Audit?
Post-Grant Options and Estoppel
What to Do When First Selecting a Mark
Most Common Client Question
Determining Likelihood of Confusion
Limited Valuable Patents in Technology Area
What is a Patent?
Common Law Trademark Rights
Standard for Getting a Patent
Joint Ventures and Dispute Resolution
Patent Examination Process
Trade Name Protection and Trademark Protection
Circle "R"
Patent Ownership and Patent Profile Analytics
Inventorship vs Ownership
What IP Should I Spend Money on First?
PTAB Final Argument Trial Dynamics
Prior Art in Prosecution vs Prior Art in Litigation
First Item on IP To-Do List
A Less Expensive Alternative
OSS Licensing Conditions
Categories of Marks
Merely Descriptive Refusal
Managing OSS
Steps to Obtaining a Patent
Goal of a Value-Driven Patent Portfolio
Confidential Information
Portfolio Dashboard - Inventor Information
Portfolio Mapping
Cost/Value Curve of Patent a Portfolio
How to Remedy Unwanted Disclosure of Confidential Information
Inventorship
Post-Litigation Challenges
Risk Profile
Sponsor
Why Is Executing an NDA Not Enough?
How is Open Source Software Enforced?
Trade Names vs Trademarks
Considerations Before Hiring IP Council
Is There Still a Place for Traditional Re-Examination?
Patent Portfolio and Budgets/Spending
Naming Problems with BioSimilars
Inventors and Patent Analytics
Open Source Software
Proper Way to Use a Trademark
Value Management and Cash Flow
Is A United States Registered Trademark Effective in Other Countries?
Why Perform Risk Profile?
Cited Art Landscape
Downside of Static Budget Allocation for Patents
Why Are Biologicals so Important?
Demonstrating BioSimilarity Under U.S. Law
Geographic Insight and Patent Profile Analytics
Seeking Money from Investors
Patent Citation Ranking
Budgeting for Drafting and Prosecution
Audit Action Sheet
The Different Types of Marks
Non-Disclosure Agreement
Contractual Intellectual Property Rights
Assessing Executive Experience
Are BioSimilars Being Approved in the US?
Common Reasons Trademarks Are Rejected
"Claims" of a Patent
Mitigating Risks of Past Damages
"Who" - Audit Action Sheet
5 Year View Point
Reasons to Consider Joint Ventures
Joint Venture Pitfalls
Engineers Not Understanding Patents
Covered Business Method Review
"Whats" - Audit Action Sheet
Merrifield Synthesis
When is a House like a Patent?
Trade Secrets
"How Much" - Audit Action Sheet
Inter Partes Review
Convergence Density
Improving Patent Portfolio Value
Risks of OSS
Limiting Issues Defined in District Court
Tracking Work History
Segmenting a Portfolio
Advantages of Registering a Trademark
How to Fix the Knowledge Gap
Backward Citations
High Risk Joint Ventures
How Do Patent Portfolio Values Become Concentrated over Time?
"TM" Symbol
How Should IP be Considered for Growth?
Signing an NDA
Patent Owner Rights
Schwegman Lundberg & Woessner & Post Grant Trial Practice
A Better Way to Allocate Patent Application Budgets
Attorneys Not Understanding the Market
Impact of PTAB
Freedom To Operate vs Clearance
Patent Infringement
Prior Art Challenge
Prior Art and Rejections
Meet David Black
Do Narrow Patents Add Value to a Portfolio?
Freedom to Operate (FTO) Process
Litigation Density
Provisional vs Non-Provisional Patent
Patent Trial and Appeal Board
Soft Assets
Two Main Value Drivers
Unlicensed Source Codes
Claim Maps and BioSimilars
Value-Driven Patent Portfolio
How can OSS Negatively Affect a Company?
Challenges When Dealing with Patent Matters
How is Open Source Incorporated into Software?
The Advantage of Filing First
Discovering Annuity Information
Golden Rule of Auditing a Patent Portfolio
Impact of Post-Grant Proceedings
Am I Required to Search for Prior Art?
Post-Grant Proceedings and Patent Enforcement
Approvals of BioSimilars in Europe
Broad Patent Claim
Secondary Meaning of a Trademark
Factors That Make a Patent Valuable
Unanticipated OSS
Importance of Freedom To Operate
Trademarks and Brand Value
Licensing Density
Types of Inventions That Are Patentable
Post-Grant Review
Repeating Competitor Audits
Office Action
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
How Big Should My First Patent Be?
Hiring Patent Council
Important Attributes to Being a Successful Patent Lawyer
Benefits of Audit Action Sheet
First Step in Performing a Patent Portfolio Audit
What is a Patent Portfolio?
Infringement on the Rights of Other Patents
Using Product Association with IP Assets
Freedom To Operate
Auction Audit Sheet - Key Issues to Address
Scope Concepts and Headnotes
Becoming a Patent Lawyer
Preventing "Genericide"
Open Source Initiative
Factors That Cause a Patent to Decline in Value
What Makes Schwegman, Lundberg & Woessner Different?
Helping In-House Council
Rebutting a Merely Descriptive Refusal
Process for Registering a Trademark in the United States
Date of First Use
Researching Competitors' IP
Value Management and Risk Management
Pre-Litigation Challenges
Biologics Price Competition and Innovation Act
The Five Components of an Open Source Software Policy
Trade Dress
4 Ways to Prepare your Patent Portfolio for Battle.
Practicing an Invention
Why Do You Enjoy Being a Lawyer?
What is Prior Art?
NDAs and Customers
Domain Registration Considerations
How Long Does an FTO Take?
Importance of Post-Grant Proceedings
Post-Grant Proceedings
Claim Abstraction Theory
Joint Venture and Financial Agreements
"SM" Symbol
Requirements to Receive a Patent
Purposes of a Trademark
